#Connected Drug Delivery Devices Market scope

[jayanthitbrc]

Global Dental Veneers Market Analysis 2024: Size Forecast and Growth Prospects

The dental veneers global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Dental Veneers Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The dental veneers market size has grown strongly in recent years. It will grow from $2.29 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing skin cancer incidence, growing awareness of skin health, focus on preventive healthcare, rise in aesthetic concerns, expansion of dermatology practices..

The dental veneers market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to global aging population, increasing focus on skin cancer prevention, rising dermatology consultations, focus on early intervention, expansion of aesthetic dermatology practices.. Major trends in the forecast period include integration of artificial intelligence (ai) algorithms, development of smartphone-compatible dermatoscopes, focus on multispectral imaging, telemedicine applications, enhanced connectivity and data sharing..

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/dental-veneers-global-market-report

Scope Of Dental Veneers Market The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Dental Veneers Market Overview

Market Drivers - Growing dental disorders are expected to propel the growth of the dental veneers market going forward. Dental disorders refer to oral disorders or oral diseases and encompass a variety of conditions that impact the teeth, gums, mouth, and related structures. Dental veneers are used for treating discoloured teeth due to root canal treatment or stains from tetracycline or other drugs, chipped or broken teeth, gaps or spaces in teeth. For instance, in August 2023, according to the '2022-23 Annual Report' released by the National Health Service, a UK-based, publicly funded healthcare system, there were 32.5 million instances of dental disorder treatments administered. This marked a significant rise of 23.2% compared to the 26.4 million treatments delivered in 2021. Therefore, growing dental disorders will drive the growth of the dental veneer market.

Market Trends - Companies operating in the dental veneers market are focusing on the introduction of advanced dental treatment devices such as UltraThineer to gain a competitive edge in the market. UltraThineer is a 3D-printed dental veneer made of advanced material and a production workflow that allows for a minimally invasive treatment option. For instance, in August 2023, Boston Micro Fabrication, a US-based company engaged in nanotechnology research and offering medical and cosmetic veneers, launched UltraThineer, one of the thinnest cosmetic dental veneers. It is designed with projection micro-stereolithography, the newly introduced 3D-printed veneers are customized to be three times thinner than traditional ones. This new method greatly streamlines the preparatory tasks for dental professionals.

The dental veneers market covered in this report is segmented –

1) By Product: Porcelain Veneers, Composite Veneers, Other Products 2) By Application: Cosmetic, Medical 3) By End Users: Hospitals, Dental Clinics, Other End Users

Get an inside scoop of the dental veneers market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13422&type=smp

Regional Insights - North America was the largest region in the dental veneers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental veneers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the dental veneers market report are 3M Corporation, Henkel AG & Co. KGaA., Koninklijke Philips N.V, Colgate-Palmolive Company, Dentsply Sirona Inc., Align Technology Inc., Straumann Group, Planmeca Oy, Ivoclar Vivadent AG, Nobel Biocare Holding AG, Ultradent Products Inc., A-dec Inc., Kulzer GmbH, MicroDental Laboratories Inc., Amann Girrbach AG, Brasseler USA LLC, Voco America Inc., Keystone Dental Group, Sun Dental Labs, Den-Mat Holdings LLC, Biolase Inc., Glidewell Dental Lab., Bego USA Inc., Removable Veneers USA, DURAthin Veneers

Table of Contents 1. Executive Summary 2. Dental Veneers Market Report Structure 3. Dental Veneers Market Trends And Strategies 4. Dental Veneers Market – Macro Economic Scenario 5. Dental Veneers Market Size And Growth ….. 27. Dental Veneers Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[adityarana1687-blog]

Wearable Patch Market Size To Reach $15.71 Billion By 2030

The global wearable patch market size is valued at USD 15.71 billion in 2030 and is projected to grow at a CAGR of 7.9% from 2024 to 2030. Wearable Patch is attached to the skin and can be worn for a couple of hours to weeks. In recent years these patches have become more popular and are most widely used for drug delivery or patient monitoring, and sports. They are also used to deliver medication such as nicotine and to treat various chronic diseases. Various companies are investing in this technology to gain a competitive advantage.

The connected wearable patch segment accounted for the highest market share in 2019. It has wireless connectivity features that help in monitoring the health of patients and delivering drugs accordingly. The factors responsible for the growth of the segment are growing concern among people related to their health and the increasing aging population with chronic diseases. Also, technological developments to boost the connected wearable patch with more data accuracy and features are anticipated to bring new advanced opportunities for the market in the coming future.

Based on the application, the clinical segment shares the highest market during the estimated period. It helps to gather information on a regular basis and then transforms data to connected devices such as laptops and smartphones so that the physicians have access to a real-time, continuous flow of data, which can avert patient worsening.

North America held the highest revenue share of 35.5% in 2019 due to its rising aging population, technological improvement in electronic skin, and increasing investment in R&D. In addition, increasing collaborations between hospitals, academic institutions, and widespread R&D activities at the industrial and academic level and increase in the scope of biomedical applications, have fueled the market growth. Moreover, the presence of major players in the region contributed to market growth.

Request a free sample copy or view report summary: Wearable Patch Market Report

Wearable Patch Market Report Highlights

The connected wearable segment dominated the market in 2019 and accounted for a revenue share of around 76.3% owing to increasing demand for electronic skin in developing countries

The clinical segment is anticipated to register the fastest growth rate of 6.4% over the forecast period

The clinical segment accounted for the highest revenue share of 50.5% in 2019 and is anticipated to maintain its dominance due to increasing investment in R&D of the medical device

North America dominated the market and accounted for a revenue share of 35.5% in 2019. This can be attributed to the rapid increase in the development of smart patches to meet the growing demand for efficient healthcare in the country

Wearable Patch Market Segmentation

Grand View Research has segmented the global wearable patch market report on the basis of type, technology, application, end use and region 

Wearable Patch Type Outlook (Revenue, USD Million, 2018 - 2030)

Temperature Patch

Glucose Patch

Heart rate and ECG Patch

Others

Wearable Patch Technology Outlook (Revenue, USD Million, 2018 - 2030)

Regular Wearable

Connected Wearable

Wearable Patch Application Outlook (Revenue, USD Million, 2018 - 2030)

Clinical

Non-clinical

Wearable Patch End Use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Ambulatory Surgical Centers

Homecare Settings

Wearable Patch Region Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Wearable Patch Market

AliveCor, Inc

VivaLNK, Inc

Cardiac Insight Inc

VitalConnect

LifeSignals, Inc

L’Oreal Group

Dexcom, Inc

GENTAG, Inc

Abbott Laboratories

Koninklijke Philips N.V.

Sensium Healthcare Ltd

Leaf Healthcare, Inc

Qualcomm Technologies, Inc

[bhavesh2022]

Europe Medical Tubing Market Analysis, Strategic Assessment, Trend Outlook and Business Opportunities 2021-2028

Business Market Insights latest offering, titled “Europe Medical Tubing Market Size and Share Analysis to 2028,” provides comprehensive insights for startups and big market players. The report covers industry performance, risk factors, growth determinants, economics of cost, and ROI streams. It combines qualitative and primary research methods, making it an essential product for companies, investors, and business strategists aiming to excel in the Europe Medical Tubing market in a projected timeframe.

Market Overview

Europe Medical Tubing market has experienced dynamic transformations in recent years, anticipated to remain an investible domain for investors in the projected time. The market is propelled by consumer preferences, regulatory parameters, and advancements in technology. Concurrently, the surge in automation has favored Europe Medical Tubing market share expansion. Advancements in manufacturing technologies have made the Europe Medical Tubing market viable and accessible, which is further expected to contribute to market growth.

In confluence with the aforementioned growth drivers, the Europe Medical Tubing market is also gauged for restraints and trends. The emerging trends in the market are analyzed in this chapter to assist market players in trying to retain their competitive edge. Strategic insights on key players and their tactics are perks of this research. This section brings forward different organic business strategies, strategic partnerships, and collaborations in the Europe Medical Tubing market.

Market Segmentation

To adequately aid their customers in a competitive Europe Medical Tubing market, enterprises must educate themselves on key segments. Streamlining market approaches is an effective application of market research. The market segmentation section focuses on product, application, and regional categories. Understanding demographics and high-ROI geographical regions helps entrepreneurs optimize their products. 

Regional Insights

The report attempts to explore both global and regional market aspects through authorized sources. Regional share, trends, key market players, and future scope are perks under this section.

Report Attributes

Details

Segmental Coverage

Material

Polyvinyl Chloride (PVC)

Polyimide/Nylons

PTFE/Thermoplastic Elastomers (TPES)

Thermoplastic Polyurethanes (TPUS)

Polyvinylidene Fluoride (PVDF)

Polypropylene and Polyethylene

Silicon

and Other

Structure

Single-Lumen

Multi-Lumen

Multi-Layer Extruded Tubing

Tapered or Bump Tubing

Braided Tubing

Balloon Tubing

Corrugated Tubing

Heat Shrink Tubing

and Others

Application

Bulk Disposable Tubing

Catheter & Cannula

Drug Delivery System

and Others

End User

Hospitals and Clinics

Ambulatory Care Centres

Medical Device Companies

Laboratories

and Others

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Compagnie de Saint Gobain SA

Nordson Corp

Optinova AB

Spectrum Plastics Group Inc

TE Connectivity Ltd

Trelleborg AB

Other key companies 

Need a Customized Market Research Report?

You can always share any specific requirements that you have, and our team will adjust the scope of research offerings as per your needs. the following are some customizations our clients ask for:

The report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Key Questions Addressed in the Europe Medical Tubing Market Research Include:

What are present Europe Medical Tubing market values, and what can be expected in the upcoming decade?

What are the key segments in the Europe Medical Tubing market?

What is the regional distribution of the Europe Medical Tubing market report?

What are the key players and their recent strategies?

What are the key factors driving Europe Medical Tubing market growth?

What are regulatory concerns and requirements businesses have to compel?

Our Unique Research Methods at Business Market Insights

We offer syndicated market research solutions and consultation services that provide complete coverage of global markets. This report includes a snapshot of global and regional insights. We pay attention to business growth and partner preferences, that why we offer customization on all our reports to meet individual scope and regional requirements.

Our team of researchers utilizes exhaustive primary research and secondary methods to gather precise and reliable information. Our analysts cross-verify facts to ensure validity. We are committed to offering actionable insights based on our vast research databases.

Author’s Bio: Bhavesh Shinde Senior Market Research Expert at Business Market Insights

[datadiscoveriesdaily]

Asthma Inhaler Device Market Growth Factors, Applications, Regional Analysis, Key Players and Forecast by 2031

The Asthma Inhaler Device Market is a critical segment within the healthcare industry, playing a pivotal role in managing and alleviating the symptoms of asthma, a chronic respiratory condition affecting millions worldwide. As of 2023, the market is witnessing significant growth, driven by various factors that contribute to the evolution and innovation of inhaler technologies.

The market overview reveals a dynamic landscape characterized by a diverse range of inhaler devices catering to the diverse needs of asthma patients. From traditional metered-dose inhalers (MDIs) to dry powder inhalers (DPIs) and nebulizers, the market showcases a spectrum of choices for both patients and healthcare providers. This diversity underscores the continuous efforts of manufacturers to enhance drug delivery mechanisms, ensuring optimal efficacy and ease of use for individuals with asthma.

To Know Global Scope and Demand of Asthma Inhaler Device Market | Request for Sample PDF: https://www.sanglobalresearch.com/enquiry/asthma-inhaler-device-market

Several drivers fuel the growth of the Asthma Inhaler Device Market. Firstly, the rising prevalence of asthma globally is a significant contributor. According to statistics from leading government health organizations, such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), asthma affects millions of people across different age groups. The increasing awareness about the condition and the importance of effective management further propels the demand for advanced inhaler devices.

Innovation and technological advancements stand out as prominent growth factors in this market. Manufacturers are investing heavily in research and development to introduce smart inhalers and connected devices, incorporating features like dose tracking and reminders. These advancements not only enhance patient adherence to prescribed treatments but also provide valuable data for healthcare professionals to tailor personalized asthma management plans.

However, the Asthma Inhaler Device Market is not without its restraints. Affordability and accessibility remain significant challenges, particularly in developing regions where a large portion of the population may lack access to advanced inhaler technologies. Additionally, concerns related to environmental impact, particularly with traditional MDIs containing greenhouse gases, are prompting regulatory interventions and a shift toward eco-friendly alternatives.

Government organizations play a crucial role in shaping the landscape of the Asthma Inhaler Device Market. For instance, regulatory agencies like the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe set standards for the approval and commercialization of inhaler devices. Compliance with these regulations is paramount for manufacturers seeking market approval, ensuring the safety and efficacy of the devices.

Companies Profiled:

    GlaxoSmithKline

    Merck & Co

    3M

    Aristopharma

    SRS PHARMACEUTICALS

    Intas Pharmaceuticals

Global Asthma Inhaler Device Market, Segmentation by Type

    Metered-Dose Inhaler

    MDI with a Spacer

    Dry-Powder Inhaler

    Other

Global Asthma Inhaler Device Market, Segmentation by Sale Channel

    Hospital

    Clinics

    Retail Pharmacies

    Other

Global Asthma Inhaler Device Market, Regional Outlook

North America (U.S., Canada, and Mexico)

Europe (Germany, France, Italy, Spain, U.K., Russia, and Rest of Europe)

Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific)

South America (Brazil, Argentina, and Rest of South America)

Middle East & Africa (South Africa, UAE, and Rest of ME&A)

Related Reports:

Hair Growth Supplements Market https://www.sanglobalresearch.com/report/hair-growth-supplements-market/3108

Digital Therapeutics Market  https://www.sanglobalresearch.com/report/digital-therapeutics-market-/3107

Health Care Wastewater Treatment Market https://www.sanglobalresearch.com/report/health-care-wastewater-treatment-market-/3106

Artificial Intelligence in Cardiology Market https://www.sanglobalresearch.com/report/artificial-intelligence-in-cardiology-market/3105

Image-guided Therapy Systems Market https://www.sanglobalresearch.com/report/image-guided-therapy-systems-market-/3104

Visit Our Blogs:

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

About Us:

At San Global Research Report, we pride ourselves on our commitment to quality and accuracy. Our team of experienced researchers utilizes a combination of quantitative and qualitative methods to ensure that our findings are both accurate and reliable. With a strong emphasis on responsiveness, transparency, and collaboration, we work closely with our clients to understand their objectives and deliver actionable insights. Learn more about our research approach and how it can benefit your business.

Contact Us:

Address: Gera Imperium Rise, Phase 2 Hinjewadi, Pune, India

San Global Research | Web: http://www.sanglobalresearch.com

Direct Line: +91 9209275355

E-mail: hello@sanglobalresearch.com

[infinitiresearch]

Prefilled Syringes Market| Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2023 – 2027

Originally published on Technavio: Prefilled Syringes Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027

Conducting market research on the Prefilled Syringes Market involves analyzing various factors such as market size, trends, key players, applications, and technological advancements. Here's an outline for a market research report on the Prefilled Syringes market:

### Prefilled Syringes Market Research Report

#### Executive Summary: - Brief overview of the Prefilled Syringes market. - Key findings and insights. - Market trends and growth prospects.

#### Introduction: - Introduction to the Prefilled Syringes market. - Historical context and evolution. - Purpose and scope of the research.

#### Market Overview: - Definition and categorization of Prefilled Syringes. - Global market size and growth projections. - Key segments within the Prefilled Syringes market.

#### Industry Trends: - Current trends shaping the Prefilled Syringes market. - Technological advancements in syringe design and materials. - Increasing demand for self-administration and biologics delivery.

#### Key Players: - Leading companies in the Prefilled Syringes market. - Market share analysis. - Strategies adopted by major prefilled syringe manufacturers.

#### Types of Prefilled Syringes: - Overview of different types of Prefilled Syringes (e.g., glass syringes, plastic syringes). - Market demand for specific types of Prefilled Syringes. - Innovations in safety features and injection systems.

#### Applications: - Current and potential applications of Prefilled Syringes. - Impact on healthcare, pharmaceuticals, and biotechnology. - Case studies highlighting successful Prefilled Syringe deployments.

#### Technological Integration: - Core technologies in Prefilled Syringe manufacturing. - Advances in needle technologies, materials, and sterilization methods. - Integration with drug delivery devices and connectivity.

#### Market Drivers: - Factors influencing market growth (e.g., patient convenience, reduction of medication errors, growth in biologics). - Challenges faced by the industry (e.g., regulatory compliance, cost considerations). - Opportunities for market expansion.

#### Regulatory Landscape: - Compliance with pharmaceutical and medical device regulations. - Quality standards for Prefilled Syringes. - Safety and labeling requirements.

#### Regional Analysis: - Regional market trends. - Key players in different regions. - Healthcare infrastructure and regulations affecting Prefilled Syringe adoption.

#### Competitive Landscape: - Analysis of competition within the Prefilled Syringes market. - Comparative assessment of key players. - Collaborations and partnerships.

#### Future Outlook: - Growth projections for the Prefilled Syringes market. - Emerging trends and opportunities. - Potential challenges and mitigating strategies.

#### Conclusion: - Summary of key findings. - Implications for pharmaceutical companies, healthcare providers, and patients. - Recommendations for product development and market positioning.

Appendices: - Technical specifications and data. - Graphs, charts, and visual representations. - References and sources.

To Learn deeper into this report , View Sample PDF

This outline provides a comprehensive structure for conducting market research on the Prefilled Syringes market. Ensure that you gather data from reliable sources, conduct a thorough analysis, and present your findings in a clear and concise manner.

For more information please contact.

[leftcomputerpost]

Global Respiratory Inhaler Device is expected to reach US$203 Billion by 2023

Global respiratory inhaler device shipments are likely to grow at over 4% in 2021, as the medical device industry makes a gradual recovery. Innovation in smart inhaler technologies is likely to be a key focus area, but manual inhalers will still account for 90% of total demand. This stark contrast reflects the status-quo in the global medical device industry, where realization of new investment and bottom-lines are concurrent.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

For any queries linked with the report, ask an analyst

https://www.futuremarketinsights.com/ask-question/rep-gb-493

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

Dry powder inhalers remain the most lucrative category

Manually operated inhaler devices will remain preferred choice among available technologies

Respiratory inhaler devices sales surging to offer improved asthma control and management

US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

Who is winning?

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) - Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching "ADHERO," which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

More Valuable Insights on Respiratory Inhaler Devices Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global respiratory inhaler devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (dry powder inhaler, metered dose inhaler, and nebulizer), technology (manually operated inhaler devices and digitally operated inhaler devices), disease indication (asthma, COPD, pulmonary arterial hypertension, other respiratory diseases), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-493                                  

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[newsinsights]

The Global Respiratory Inhaler Devices Market to grow at 4.4% CAGR through 2030

Global respiratory inhaler device shipments are likely to grow at over 4% in 2021, as the medical device industry makes a gradual recovery. Innovation in smart inhaler technologies is likely to be a key focus area, but manual inhalers will still account for 90% of total demand. This stark contrast reflects the status-quo in the global medical device industry, where realization of new investment and bottom-lines are concurrent.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

Request For Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-493

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

Dry powder inhalers remain the most lucrative category

Manually operated inhaler devices will remain preferred choice among available technologies

Respiratory inhaler devices sales surging to offer improved asthma control and management

US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

“Some of the leading players are working on technologies that would enable monitoring and correction of inhalation techniques in the near future. They are developing smart inhalers that will use the Bluetooth technology to monitor inhaler use in patients. While several developments are underway, industry experts are cautiously examining the potential of smart inhalers to ensure all potential concerns pertaining to the novel technologies are ironed out. However once launched, smart technology can help the market gain momentum at accelerated pace in the near future,” said a lead analyst at FMI.

Who is winning?

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) - Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching "ADHERO," which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

More Valuable Insights on Respiratory Inhaler Devices Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global respiratory inhaler devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (dry powder inhaler, metered dose inhaler, and nebulizer), technology (manually operated inhaler devices and digitally operated inhaler devices), disease indication (asthma, COPD, pulmonary arterial hypertension, other respiratory diseases), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Request For Table Of Content @ https://www.futuremarketinsights.com/reports/respiratory-inhaler-devices-market/table-of-content

Key Questions Answered in the Report

Which is the most lucrative market for respiratory inhaler devices?

US currently leads the global market for respiratory inhaler devices. Sales in US will be over 40% of total demand throughout the forecast period.

Which is the top-selling respiratory inhaler device?

Dry powder inhalers are highly sought-after in every market. The demand for dry powder inhalers is expected to remain high in the near future, especially due to ease of usage and precision in drug delivery.

Which technology are respiratory inhaler device manufacturers using?

Manually operated inhaler devices continue to remain the leading choice among patients with respiratory ailments. While the availability of digitally operated devices is increasing, sales is likely to accelerate at a slower pace in comparison to the former.

Which are some of the leading companies offering respiratory inhaler devices?

Some of the leading companies offering respiratory inhaler devices are AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc., Koninklijke Philips N.V., Merck & Co., Inc., among others.

[marketresearchstrategy]

Electronic Clinical Outcome Assessment Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2026

The Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market Report added by Reports and Data offers extensive knowledge and information about the Electronic Clinical Outcome Assessment (eCOA) Solutions market with regards to market size, market share, growth influencing factors, opportunities, demands, consumer behavior, market drivers and restraints, overall competitive landscape, and current and emerging trends. The research study offers valuable insights into the business strategies, distribution channels, and value chain analysis. The report also offers positive projections of the market scenario in the coming years through in-depth assessment of the key markets features and the geographical spread of the industry. The report strives to present the reader with deep insights of the market that can assist them in making fruitful business decisions and strategic investment plans.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1037

The Electronic Clinical Outcome Assessment (eCOA) Solutions market report offers key insights into market scope along with emerging growth opportunities over the forecast period. The report also provides information about the competitive landscape of the global Electronic Clinical Outcome Assessment (eCOA) Solutions market. The global Electronic Clinical Outcome Assessment (eCOA) Solutions market is fragmented due to presence of numerous key players on a global and regional scale. Key players are focused on mergers and acquisitions, joint ventures, collaborations, partnerships, and research and development activities to expand their product portfolio and gain a robust footing in the market.

Key Companies Operating in the Electronic Clinical Outcome Assessment (eCOA) Solutions Market and profiled in the report are:

OmniComm Systems, eClinical solutions, CRF Health, Oracle Corporation, Paraxel International Corporation, Kayentis, Medidata Solution, Inc., Merge Healthcare Incorporated and  ERT Clinical.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1037

The report provides a significant assessment of the recent market trends, revenues, segments, and key regions across the globe. The regional analysis covers major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report analyzes key regions for production and consumption patterns, import/export, market share, revenue contribution, growth rate, and supply and demand ratio for the forecast period 2021-2028. It also discusses the impact of government regulations, macro- and micro-economic factors, and economic growth of the region on overall market growth.

Regional analysis covers:

North America (U.S.A., Canada)

Europe (U.K., Italy, Germany, France, Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @ https://www.reportsanddata.com/report-detail/electronic-clinical-outcome-assessment-ecoa-solutions-market

Type (Revenue, USD Million; 2018-2026)

Web-based Solution

Licensed Industries

Cloud-based

Application Outlook (Revenue, USD Million; 2018-2026)

Hospitals

Contract Research Organizations

Academic institutes

Pharma and biotech companies

Medical Device Manufacturers

Key Questions Answered by the Report:

What was the market size of the global Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2020? At what rate is the market expected to grow over the forecast period?

What are the key growth driving and restraining factors of the Electronic Clinical Outcome Assessment (eCOA) Solutions market?

What are key opportunities and growth prospects of the Electronic Clinical Outcome Assessment (eCOA) Solutions industry is expected to witness over the forecast period?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

Which region is expected to dominate the market growth over the forecast period?

Which segments are expected to register lucrative growth over the forecast period?

What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1037

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

Browse more related reports:

Hemodialysis Concentrates Market: https://www.reportsanddata.com/report-detail/hemodialysis-concentrates-market

Intranasal Drug Delivery Devices Market: https://www.reportsanddata.com/report-detail/intranasal-drug-delivery-devices-market

Cardiac Output Monitor Market: https://www.reportsanddata.com/report-detail/cardiac-output-monitor-market

Negative Pressure Wound Therapy Devices Market: https://www.reportsanddata.com/report-detail/negative-pressure-wound-therapy-devices-market

Medical Workstations Market: https://www.reportsanddata.com/report-detail/medical-workstations-market

[databridgemarket456]

Connected drug delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 928.38 million by 2028 and will grow at a CAGR of 16.69% in the above mentioned forecast period.

[ankit2369]

Ophthalmic Lasers Market-  Share, Global Market Growth Analysis, Size

The Global “

Ophthalmic Lasers

” Market reflects an impressive growth owing to the growing prevalence of refractive errors across the world. According to a report, published by Fortune Business Insights, titled, “Ophthalmic Lasers Market: Global Market Analysis, Insights and Forecast, 2019-2026” the Global Ophthalmic Lasers Market is expected to register a CAGR of 5.3% between 2019 and 2026. In addition to this, the global market was worth US$ 479.0 Mn in 2018 and is anticipated to reach US$ 722.0 Mn by 20226.  

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/ophthalmic-lasers-market-100952

Detailed Table of Content:

·         Introduction

o    Research Scope

o    Market Segmentation

o    Research Methodology

o    Definitions and Assumptions

·         Executive Summary

·         Market Dynamics

o    Market Drivers

o    Market Restraints

o    Market Opportunities

·         Key Insights

o    Epidemiology Overview: Prevalence of Key Ocular Diseases, 2018

o    Technology Advances, Ophthalmic Lasers

o    Key Mergers, and Acquisitions

o    Pricing Analysis, Key Players, 2018

·         Global Ophthalmic Lasers Market Analysis, Insights and Forecast, 2015-2026

o    Key Findings / Summary

o    Market Analysis, Insights and Forecast – By Type

§  Excimer Lasers

§  Femtosecond Lasers

§  Nd Yag Lasers

Continued…

Market Segmentation:

By Type

·         Excimer Lasers

·         Femtosecond Lasers

·         Nd Yag Lasers

·         Diode Lasers

·         Others

By Technology

·         Photodisruption

·         Selective Laser Trabeculoplasty

·         Photocoagulation

By Application

·         Cataract Treatment

·         Glaucoma Treatment

·         Refractive Errors Treatment

·         Others

By End User

·         Ophthalmic Laser Centers

·         Hospitals· Others

By Geography

·         North America (the USA and Canada)

·         Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·         Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·         Latin America (Brazil, Mexico and Rest of Latin America)

·         Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Hip Replacement Market

Connected Drug Delivery Devices Market

Dermal Fillers Market

Medical Devices Market

Blood Pressure Monitors Market

Guidewire Market

Hyaluronic Acid Based Dermal Fillers Market

Surgical Sutures Market

Diabetes Monitoring Devices Market

[sandlerresearch]

Augmented Reality in Healthcare - Thematic Research published on

https://www.sandlerresearch.org/augmented-reality-in-healthcare-thematic-research.html

Augmented Reality in Healthcare - Thematic Research

Augmented Reality in Healthcare – Thematic Research

Summary

Augmented reality (AR) technology allows the user to see the real world overlaid with digital data. Ultimately, AR could be the next mobile computing platform, with the potential to replace smartphones as the primary connected device in the next decade. GlobalData forecasts that the global AR market will be worth $76bn by 2030, up from $4bn in 2018.

There are several potential use cases for AR in the healthcare sector. The area where AR may have the greatest impact is visualizing complex biological processes to facilitate the early stages of drug discovery. AR is currently used to train medical students but can also be adapted to educate patients on their own health conditions. Other use cases for AR in healthcare include improving the delivery of mental health care, increasing the safety and precision of invasive procedures, improving the efficiency of administrative processes, and easing the integration into telemedicine. Following the COVID-19 outbreak, AR has proven particularly useful for medical students as they can be trained virtually. Similarly, through integrating AR into telemedicine some healthcare specialists can work remotely.

This report explores the theme of augmented reality in healthcare, through coverage of smart glasses, smartphones, AR headsets, AR healthcare apps and more.

Scope

– This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies. – The report covers the augmented reality in healthcare theme. – It includes case studies of emerging technology trends.

Reasons to Buy

– Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. – Corporate executives and investors who want to outperform their competitors need to understand all the themes that impact their sector. However, many of these themes are, by definition, outside of the core competencies of company boardrooms because they typically originate from external industries. – This augmented reality in healthcare thematic report provides a top-down outlook for the key players and trends over the next few years.

[market-research-future]

Injection Pen Market Overview, Key Companies Profile

Global Injection Pen Market Research Report: By Type (Disposable Injection Pens, Others), by Product (Insulin Pens, Pen Needles), by Therapy (Diabetes, Others), by Distribution Channel (Hospital Pharmacies, Others), by End-User – Global Forecast Till 2023

Injection Pen Market Overview

Healthcare sector is already underway towards revolution with competition amid key players getting intense and growing aggression to develop devices that sync well with latest connected devices. Similarly, injection pen is one of the crucial innovations in the field of drug delivery. Market Research Future estimated that the global injection pen market would attain a CAGR of 6.5% during the forecast period 2017-2023.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6146

Manufacturers recognizing the importance of advanced drug delivery devices, increased investment in digital and healthcare analytics are some of the modern trends that might spur the growth of the global injection pen market. Consumers inclination on personalized and smart products has led to increased demand insights for injection pens. Rapid scaling and sophisticated service offering by the service providers have also helped to uphold the growth of the global market. Moreover, growing prevalence of chronic diseases such as osteoporosis and diabetes are anticipated to drive the global injection pen market. Changing lifestyle, unhygienic food consumption, and a growing number of patients who require daily dose of insulin are some of the factors that are of root disease outbreak, leading to increased numbers in patients.

Big technology players and venture capitalists are bringing high-tech product architectures that are creating lucrative opportunities for the healthcare industries.

Injection Pen Market Competitive players

Industry leaders are rapidly shifting from the beta test and experiments to full-fledged product building. These leading giants include the

Novo Nordisk

Ypsomed

Sanofi

Owen Mumford

F. Hoffman-La Roche

Jiangsu Delfu Medical Device Co. Ltd.

Pfizer

Becton Dickinson and Company

Biocon Ltd.

Haselmeier

Merck

AstraZeneca

Eli Lilly

Novartis

Injection Pen Market Segmentation

The rise in R&D activities in drug delivery is anticipated to play a major role in uplifting the growth graph of the global injection pen market during the forecast period.

The global injection pen market is broadly classified based on factors such as type, product, therapy, and end-user.

Based on type, the global injection pen market is bifurcated into disposable injection pens and reusable injection pens.

By product, the global market is segmented into pen needles and insulin pens.

Moreover, the global injection pen market is also segmented based on various therapies such as diabetes, fertility, growth hormone therapy, and osteoporosis.

The end-user segment is classified as home care, hospital, and clinics.

Injection Pen Market Regional Analysis

The Americas dominate the global injection pen market and are expected to maintain its influence during the forecast period. The leading position of the region in the global market is attributed to high adoption rate of injection pens and growing awareness of the drug delivery devices. Existence of leading market giants in Canada and the U.S. is encouraging the growth of the pen injection market in the region.

Following the Americas, Europe has a leading role in the global market, owing to burgeoning diabetics. Growing cases of diabetes have forced manufacturers to develop effective and convenient ways to handle the disease, as diabetes requires day-to-day administration of insulin injections. Thus, feasibility of self-managing the disease has boosted the demand for injection pen in region.

Moreover, the Asia Pacific is an emerging region with immensely growing population; the ratio of patient population with chronic is high. Rise in the figures of diabetics and increased healthcare expenditure has stimulated the growth of the global injection pen market.

The Middle East has the lowest share in the global injection pen market; however, upcoming healthcare investments led by some industrial players is expected to spur the growth rate of the regions.

Injection Pen Industrial updates

Biocorp, healthcare connected device maker has launched a cap for pen injectors that is internet-connected and transmit dosage information to a mobile app. The company stated that it is in talks with Sanofi’s diabetes care platform for negotiations. Its smart sensor cap, named Mallya is the only connected device with injections pens that is accessed to attain the accuracy requirements to achieve CE Class IIb classification by EU regulators. Earlier, in 2016, Companion Medical based in San-Deigo got FDA clearance for the wireless-enabled smart insulin pen, named Inpen.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

…Continued

Get More Information on Injection Pen Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/injection-pen-market-6146

Brows More Healthcare Related Research Reports:

Biopsy Devices Market Applications, Size | Share and Trends, 2022

Population Health Management Market Size, Share, Growth, Industry Trends Analysis, Forecast 2023

Cosmetic Surgery Market Size, Growth and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

[freefestwinner]

Global Big Data in the Healthcare & Pharmaceutical Market Overview, Size, Share and Trends 2030

Summary - A new market study, titled "Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts" has been featured on WiseGuyReports.

 “Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

ALSO READ: https://www.wfmj.com/story/42346791/big-data-in-healthcare-pharmaceutical-market-2020-strategy-analysis-business-overview-and-opportunities-to-2030

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

 SNS Telecom & IT estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone.  Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

 The “Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

 The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

 Topics Covered

 The report covers the following topics:

  - Big Data ecosystem

  - Market drivers and barriers

  - Enabling technologies, standardization and regulatory initiatives

  - Big Data analytics and implementation models

  - Business case, application areas and use cases in the healthcare and pharmaceutical industry

  - Over 40 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders

  - Future roadmap and value chain

  - Profiles and strategies of over 270 leading and emerging Big Data ecosystem players

  - Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders

  - Market analysis and forecasts from 2018 till 2030

 Forecast Segmentation

 Market forecasts are provided for each of the following submarkets and their subcategories:

  Hardware, Software & Professional Services

  - Hardware

  - Software

  - Professional Services

 Horizontal Submarkets

  - Storage & Compute Infrastructure

  - Networking Infrastructure

  - Hadoop & Infrastructure Software

  - SQL

  - NoSQL

  - Analytic Platforms & Applications

  - Cloud Platforms

  - Professional Services

  Application Areas

  - Pharmaceutical & Medical Products

  - Core Healthcare Operations

  - Healthcare Support, Awareness & Disease Prevention

  - Health Insurance & Payer Services

  - Marketing, Sales & Other Applications

  Use Cases

  - Drug Discovery, Design & Development

  - Medical Product Design & Development

  - Clinical Development & Trials

  - Precision Medicine & Genomics

  - Manufacturing & Supply Chain Management

  - Post-Market Surveillance & Pharmacovigilance

  - Medical Product Fault Monitoring

  - Clinical Decision Support

  - Care Coordination & Delivery Management

  - CER (Comparative Effectiveness Research) & Observational Evidence

  - Personalized Healthcare & Targeted Treatments

  - Data-Driven Preventive Care & Health Interventions

  - Surgical Practice & Complex Medical Procedures

  - Pathology, Medical Imaging & Other Medical Tests

  - Proactive & Remote Patient Monitoring

  - Predictive Maintenance of Medical Equipment

  - Pharmacy Services

  - Self-Care & Lifestyle Support

  - Digital Therapeutics

  - Medication Adherence & Management

  - Vaccine Development & Promotion

  - Population Health Management

  - Connected Health Communities & Medical Knowledge Dissemination

  - Epidemiology & Disease Surveillance

  - Health Policy Decision Making

  - Controlling Substance Abuse & Addiction

  - Increasing Awareness & Accessible Healthcare

  - Health Insurance Claims Processing & Management

  - Fraud & Abuse Prevention

  - Proactive Patient Engagement

  - Accountable & Value-Based Care

  - Data-Driven Health Insurance Premiums

  - Marketing & Sales

  - Administrative & Customer Services

  - Finance & Risk Management

  - Healthcare Data Monetization

  - Other Use Cases

 Regional Markets

  - Asia Pacific

  - Eastern Europe

  - Latin & Central America

  - Middle East & Africa

  - North America

  - Western Europe

  Country Markets

  - Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany,  India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK,  USA

 Key Questions Answered

 The report provides answers to the following key questions:

  - How big is the Big Data opportunity in the healthcare and pharmaceutical industry?

  - How is the market evolving by segment and region?

  - What will the market size be in 2021, and at what rate will it grow?

  - What trends, challenges and barriers are influencing its growth?

  - Who are the key Big Data software, hardware and services vendors, and what are their strategies?

  - How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?

  - What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?

  - Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

  Key Findings

 The report has the following key findings:

  - In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than $7 Billion by the end of 2021.

  - Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.

  - Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.

  - The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3306934-big-data-in-the-healthcare-pharmaceutical-industry-2018

About Us: Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.  

 Contact Us:

NORAH TRENT                                                    

sales@wiseguyreports.com      

Ph: +162-825-80070 (US)                          

Ph: +44 203 500 2763 (UK)      

[anjrawat]

Medical & Pharma Events in the United Arab Emirates

Today, UAE is one of the largest economies in the MENA regions. The discovery of oil in the country has significantly improved the standard of living over the past 50 years. Along with economic growth, the UAE government is equally taking care of its healthcare system. In order to provide world-class healthcare facilities to its citizens, today the UAE is significantly expanding and upgrading its healthcare infrastructure with modern healthcare equipment, medical devices and electronics, health diagnostics, and many others.

In order to provide a platform for various stakeholders in the healthcare sector to connect with each other, every year the UAE organises a significant number of pharmaceutical and medical events in the country. Among the various Medical & Pharma events held throughout the year in the country, we have sorted some of the leading one, in order to provide a rough idea about the magnitude of opportunity that the country holds for the pharmaceutical and biotech companies. Here is a list of top medical and pharma events in the United Arab Emirates  -

Dubai International Pharmaceuticals & Technologies Conference and Exhibition (DUPHAT-2021)

09 - 11 March 2021

Venue - DICEC, Dubai, UAE

Organised by INDEX® Conferences & Exhibitions Organisation, DUPHAT is one of the premier healthcare events in the MENA region. DUPHAT provides a complete solution to the pharma industry, from manufacture to supply to the end consumer.

DUPHAT-2021 is supposed to be held between 09 - 11 March 2021. It will be the 25th edition of the DUPHAT.  The previous edition had hosted over 33,000 professional and 750 brands and exhibiting companies from 75+ countries. DUPHAT-2021 is expected to inspire pharmacists, healthcare and marketing professionals, researchers, academics, scientists, clinicians, students and exhibiting companies around the world in the next years too. 

International Conference of Pharmacy and Medicine (ICPM)

6 - 8 April 2021

Venue - Dubai, UAE

International Conference of Pharmacy and Medicine (ICPM) provides a unique platform to the healthcare companies to find new business opportunities (B2B) in a most effective way. It also provides a professional local guide to make everybody’s goals reachable and in the long term successful. Organised by Al Madinah Al Dwalia Exhibitions And Conference Management, the 2021 edition of the ICPM will be held between 6 - 8 April, at HealthCare City, Dubai, UAE. 

International Conference on Medical, Biological and Pharmaceutical Sciences (ICMBPS)

17 - 18 December 2020

Venue - Dubai, UAE

With the aims to bring together leading academic scientists, and researchers and research scholars to exchange and share their experiences and research results on all aspects of Medical, Biological and Pharmaceutical Sciences the ICMBPS 2020 will be held on Dec 17-18, 2020 in Dubai, UAE. The conference will cover diverse topics such as bioinformatics, bio-robotics, clinical and health informatics, pharmaceutical care, tissue engineering and many others, which make it one of the must-attend events for the healthcare professionals. 

Arab Health Congress

 21 - 24 June 2021

World Trade Centre, Dubai, UAE

The Arab Health Congress is rescheduled to 21 - 24 June 2021. It is one of the largest healthcare events in the MENA region. The 2021 edition is expected to have the presence of 4,000+ exhibiting companies and 106,300+ professionals from 159 countries. Arab Health provides a wide range of benefits to healthcare professionals and exhibiting companies such as generating new business, increase in brand exposure, the launch of new products & services and opportunity to network with industry leaders & potential buyers.

International Conference on Medical and Health Sciences (ICMHS)

26 - 27 December 2020, 

Venue - Dubai, UAE

Organized by Researchfora, the 784th International Conference on Medical & Health Science (ICMHS 2020) will be held in Dubai, United Arab Emirates. The ICMHS conference aims to provide the platform to the students, doctors, researchers, practitioners, and academicians to share the knowledge, ideas and researches that are in trends in the field of medical & health science. Due to the COVID-19 pandemic, the Organizing Committee has provided the presenters with the opportunity to present the online/Video presentation, in addition to the oral presentation and poster presentation

International Conference on Drug Delivery and Formulations

23 - 24 April 2021

Venue - Dubai, UAE

The 5th Edition of the International Conference on Drug Delivery and Formulations will be held on 23 & 24 April 2021 in Dubai, UAE. The 2021 edition of the event is themed around “Exploring New Research and Innovative Developments in Pharmaceutical.” 

The two-day event will be marked with keynote presentations, workshops and symposiums, oral presentations, exhibitions on new emerging technologies, special sessions and poster presentations. The scientific sessions will cover the topic on advances in drug delivery system, medical devices, drug discovery, nanotechnology & drug carrier system, pharmacovigilance, drug safety and business opportunities in drug delivery.

Annual Congress on Advances in Pharmaceutical Sciences (Pharmaceutics 2020)

14 - 15 December 2020 Venue-  Dubai, UAE

The Annual Congress on Advances in Pharmaceutical Sciences (Pharmaceutics) is one of the leading Pharmaceutics events in the United Arab Emirates. The Pharmaceutics provide a unique platform to the renowned pharmacologists, pharma researchers, and health care professionals, fellowship holders, residents, pharmaceutical industries and healthcare industries in the field of pharmacy to showcase their latest innovation ideas, thoughts, and suggestions. 

Pharmaceutics 2020 is supposed to be held on 14-15, December 2020. The two-day gathering will embrace keynote speeches, oral, poster and video presentations. Top pharmaceutical companies such as Novartis, AstraZeneca, Sanofi, Pfizer, Hoffman-La Roche, Gilead and many others are expected to show their presence. 

International Conference on Pharmacy and Pharmaceuticals

28-29 January 2021

Venue - Dubai, UAE

International Conference on Pharmacy and Pharmaceutical Sciences aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of pharmacy and pharmaceutical sciences.

The two-day conference will hold discussions around key pharmaceutical topics such as clinical development, exploratory development, pharmaceutics, drug delivery, biomedicine, medical pharmacology, pharmaceutical analysis, pharmacy practice, innovations in clinical development, computational chemistry and molecular drug design and many others. 

The government and health bodies are coming up with many new investment opportunities for healthcare companies to increase local drug manufacturing and reduce reliance on imported products. The medical & pharma events held in the country provide some of the best opportunities to the healthcare professionals, investors and pharmaceutical companies to understand the healthcare sector of the country. Along with it also provide scope for collaboration, networking and brand building.